Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2377645-90-2 | 4-Chloro-3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzoic acid | Csub11/subHsub9/subClNsub2/subOsub4/sub |
| 2377770-18-6 | (2-(3,6-Dimethoxy-9H-carbazol-9-yl)ethyl)phosphonic acid | Csub16/subHsub18/subNOsub5/subP |
| 2378104-61-9 | 4-(5,6-dimethoxythieno[2,3-b]pyridin-2-yl)-4-oxobutanoic acid | Csub13/subHsub13/subNOsub5/subS |
| 2378104-86-8 | 2-Bromo-5.6-dimethoxynicotinaldehyde | Csub8/subHsub8/subBrNOsub3/sub |
| 2378356-17-1 | 2'-(9H-Carbazol-9-yl)-[1,1'-biphenyl]-4-amine | Csub24/subHsub18/subNsub2/sub |
| 2379325-42-3 | Duloxetine EP Impurity F | Csub18/subHsub19/subNOS .Csub2/subHsub2/subOsub4/sub |
| 2379402-85-2 | Bortezomib Impurity 5 | Csub19/subHsub22/subNsub4/subOsub4/sub |
| 2379460-04-3 | 9-Chloronaphtho[2,1-b]benzofuran | Csub16/subHsub9/subClO |
| 2379694-79-6 | 1,10-Phenanthroline-3,8-dicarboxylic acid | Csub14/subHsub8/subNsub2/subOsub4/sub |
| 2379717-75-4 | 1-Chloro-8-phenyldibenzofuran | Csub18/subHsub11/subClO |
| 2380027-49-4 | Src Inhibitor 3 | Csub34/subHsub32/subClFNsub8/subOsub4/sub |
| 2380230-73-7 | 2-[2-[[3-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]phenyl]carbonylamino]phenyl]ethanoic acid | Csub27/subHsub29/subNsub3/subOsub3/sub |
| 2381089-83-2 | Retatrutide | Csub22/subsub7/subHsub35/subsub4/subNsub48/subOsub69/sub |
| 2381400-91-3 | 2-Methyl-2-propanyl (4S)-4-amino-3,3-difluoro-1-pyrrolidinecarboxylate | Csub9/subHsub16/subFsub2/subNsub2/subOsub2/sub |
| 2381627-87-6 | Carfilzomib Impurity 59 | Csub14/subHsub25/subNOsub4/sub |
| 2381854-90-4 | Fmoc-N-Me-3-(4-py)-L-Ala | Csub24/subHsub22/subNsub2/subOsub4/sub |
| 2382442-97-7 | Oseltamivir Impurity 207 | Csub12/subHsub18/subOsub4/sub |
| 2382664-60-8 | 4-Chloro-2-(morpholinomethyl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | Csub19/subHsub18/subClNsub3/subOsub4/subS |
| 2384108-14-7 | Cefazolin EP Impurity B | Csub16/subHsub20/subNsub4/subOsub4/subSsub3/sub |
| 2385124-34-3 | 3-bromo-5-fluoro-N-methylpyridin-2-amine | Csub6/subHsub6/subBrFNsub2/sub |
| 2387020-93-9 | Terbutaline Impurity 30 | Csub8/subHsub7/subBrOsub3/sub |
| 2387518-94-5 | 4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-2-fluoro-3-methylaniline | Csub13/subHsub11/subFNsub4/subO |
| 2387538-18-1 | 2-Chloro-4-neopentylpyridine | Csub10/subHsub14/subClN |
| 2387728-91-6 | 1-[4-Ethoxy-3-(hydroxymethyl)phenyl]-2-[(2-methyl-2-propanyl)amino]ethanol | Csub15/subHsub25/subNOsub3/sub |
| 2389125-23-7 | Y6-BO-4F | Csub88/subHsub98/subFsub4/subNsub8/subOsub2/subSsub5/sub |
| 2389125-24-8 | BTP48C11-2CHO | Csub66/subHsub98/subNsub4/subOsub2/subSsub5/sub |
| 2392930-05-9 | 2-Chloro-4,6-di(dibenzofuran-1-yl)-1,3,5-triazine | Csub27/subHsub14/subClNsub3/subOsub2/sub |
| 2395025-37-1 | Cefoxitin EP Impurity F | Csub17/subHsub19/subNsub3/subOsub8/subSsub2/sub |
| 2396570-49-1 | 2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine | Csub30/subHsub21/subNsub9/sub |
| 2397634-28-3 | 1-N,1-N,3-N,3-N,5-N-pentakis-phenylbenzene-1,3,5-triamine | Csub36/subHsub29/subNsub3/sub |
| 2402776-83-2 | Baricitinib Impurity 24 | Csub16/subHsub17/subNsub7/subOsub2/subS |
| 2402776-84-3 | Baricitinib Impurity 16 | Csub23/subHsub27/subNsub9/subOsub4/subSsub2/sub |
| 2407527-16-4 | Enlicitide chloride | Csub82/subHsub11/subsub0/subClFNsub14/subOsub15/sub |
| 2407529-33-1 | (1R,3R)-1-[2,6-Difluoro-4-[[1-(3-fluoropropyl)-3-azetidinyl]amino]phenyl]-β,β-difluoro-1,3,4,9-tetrahydro-3-methyl-2H-pyrido[3,4-b]indole-2-propanol (2R,3R)-2,3-dihydroxybutanedioate (1:1) | Csub27/subHsub31/subFsub5/subNsub4/subO .Csub4/subHsub6/subOsub6/sub |
| 2407535-11-7 | 5-[[1-(3-Fluoropropyl)azetidin-3-yl]amino]pyridine-2-carbaldehyde | Csub12/subHsub16/subFNsub3/subO |
| 2408008-09-1 | 9-Phenyl-N-(2-phenylphenyl)carbazol-2-amine | Csub30/subHsub22/subNsub2/sub |
| 2408053-56-3 | Sacubitril Methyl Ester | Csub23/subHsub27/subNOsub5/sub |
| 2408294-08-4 | Methanesulfonato 1,1'-Bis(di-tert-butylphosphino) ferrocene (2'-amino-1,1'-biphenyl-2-yl) palladium(II) | Csub39/subHsub49/subFeNOsub3/subPsub2/subPdS |
| 2408495-96-3 | Budesonide 21-Butyrate Impurity | Csub29/subHsub40/subOsub7/sub |
| 2408495-97-4 | Budesonide Impurity 30 | Csub29/subHsub38/subOsub7/sub |
| 2408705-92-8 | 2,4-Dichloro-6-(dibenzo[b,d]furan-1-yl)-1,3,5-triazine | Csub15/subHsub7/subClsub2/subNsub3/subO |
| 2408968-92-1 | (1-(Aminomethyl)-2-oxabicyclo[3.1.1]heptan-5-yl)methanol hydrochloride | Csub8/subHsub16/subClNOsub2/sub |
| 2409005-96-3 | 3-(5-Bromo-6-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione | Csub13/subHsub10/subBrFNsub2/subOsub3/sub |
| 2409132-63-2 | Elagolix Formamide | Csub29/subHsub24/subFsub5/subNsub3/subOsub4/sub |
| 2409479-29-2 | (R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one | Csub27/subHsub30/subFsub3/subNsub9/subO |
| 2409562-95-2 | 1-Bromo-5-(tert-butyl)-2,3-dichlorobenzene | Csub10/subHsub11/subBrClsub2/sub |
| 2410075-48-6 | 7-Ketoabiraterone acetate | Csub26/subHsub31/subNOsub3/sub |
| 2410195-20-7 | Imatinib Impurity K | Csub17/subHsub15/subNsub5/subO |
| 2410195-23-0 | Imatinib Dipiperazine Impurity | Csub41/subHsub45/subNsub9/subOsub2/sub |
| 2410284-89-6 | Nintedanib Impurity 22 | Csub22/subHsub30/subNsub6/subOsub2/sub |